Data on the therapeutic role of biological agents in CTDs-ILD is preliminary and controversial.
Although preexisting ILD is not a contraindication for these agents, until more information …

Objective Cyclophosphamide is considered the treatment of choice for interstitial lung
disease (ILD) secondary to systemic sclerosis (SSc), albeit having a minimal effect. Although …

Objective. To identify possible differences in morbidity and mortality between men and women
with systemic sclerosis (SSc) by examining a homogeneous cohort at a single academic …

Objective To examine the efficacy and safety of interleukin-6 inhibition by tocilizumab (TCZ)
in difficult-to-treat, real-world patients with systemic sclerosis (SSc). Methods Twenty-one …

… patients eligible for HSCT / ST Panopoulos et al. … in scleroderma patients eligible for HSCT
/ ST Panopoulos et al. … Outcomes in scleroderma patients eligible for HSCT / ST Panopoulos …

Primary antiphospholipid syndrome (PAPS) is an entity characterized by spontaneous and
recurrent abortion and recurrent vascular thromboses (arterial and venous). Intracardiac …

T cell functional differentiation is mediated by lineage-specific transcription factors. T helper
17 (Th17) has been recently identified as a distinct Th lineage mediating tissue inflammation…

… at St Jude Children's Research Hospital. Recombinant human G-CSF (Amgen, Thousand
Oaks, CA) was diluted in sterile PBS containing 1% low-endotoxin BSA (Sigma, St Louis, MO). …

Objective: The aim of the present study was to evaluate and compare the cytotoxic effects of
Biodentine and MTA on dental pulp stem cells (DPSCs) and to assess cell viability and …

Objective Although perturbations in mitochondrial function and structure have been described
in the intestinal epithelium of Crohn’s disease and ulcerative colitis patients, the role of …